See the Presentations of the 2023 Perú Sessions

Jornadas Perú 2023

The XLVII SOLACI Regional Sessions – 16th Andean Region took place in Lima, Peru, between November 16 and 17, 2023.It was an extremely successful event that featured the participation of prestigious national and international guests and a high-level scientific program.

Below, we share some of the presentations that were made during the Sessions.

Dra. Carla Agatiello (ARG) | “MIL Train More MIL – Towards gender equity in interventional cardiology”.

 

Dra. Alfonsina Candiello (ARG) | “SOLACI Reperfusion Group”.

 

Dres. Andrés Aldazábal – Ricardo Coloma – Carlos Mariño | “SOL-SOLACI Peru Solidarity Case”.

 

Dr. Carlos Mariño | “Percutaneous VP Pulsta implantation in Peru. Initial experience”.

 

Dr. Carlos Soledispa | “A case, a lesson – Bariatric Gastric Embolization: Should we embolize the right gastric artery?”.

 

Dres. Carlos Mariño | “A Case A Teaching – Case 3 – Pediatric Structural”.

 

Dr. Cecilia Cuevas | “My experience at MIL Entrenan Más MIL 2023”.

 

Dr. Cesar Conde Vela | “Update on interventional therapy of the mitral valve”.

 

Dr. Manuel Chacón | “Update on invasive drug strategy”.

 

Dra. Erika Ludeña Riveros | “One case, one lesson – One day, two cardiogenic shocks”.

 

Dr. Gorky Mori Pinedo | “Bifurcations in acute coronary syndrome”.

 

Dr. Marcelo Halac | “SOL SOLACI PROGRAM”.

 

Dr. Jhonatan Nina | “Young Cardiologists Competition – Aortic Valvuloplasty with Transradial Balloon”.

 

Dr. Jorge Alejandro Gil Romero | “Appendage closure: which patients benefit from this intervention?”.

 

Dr. José María Hernández | “Interventionism on the tricuspid valve: current status”.

 

Dr. Kevin Velarde Acosta | “Young Cardiologists Competition – Acute Lad Occlusion After IVUS Leading to Urgent PCI Complicated with Coronary Perforation”.

 

Dr. Luis Urna | “Late revascularization in infarction: a valid strategy in our region?”.

 

Dr. Luis Urna | “Chronic coronary syndrome. Does the new classification help us in the therapeutic decision?”.

 

Dr. Marcio Montenegro | “Challenges of tricuspid regurgitation today”.

 

Dr. Marco López | “Heart attack network in Peru: Utopia or reality?”.

 

Dres. Carlos Mariño, Andrés Aldazábal | “SOL-SOLACI: Interventionism in Adult Congenital Heart Disease”.

 

Dr. Mario Araya | “Complex scenarios at bifurcations”.

 

Dr. Piero Custodio Sánchez | “Importance of Myocardial Infarction Networks”.

 

Dr. Ricardo Quizhpe | “Percutaneous closure of the left atrial appendage: Watchman Flex”.

 

Dr. Ricardo Quizhpe | “A case, a lesson.”

 

Dr. Rubén Piraino | “Functional Coronary Angiography”.

 

Dr. Rubén Piraíno | “Current scenarios for the use of drug balloons.”

 

Dr. Tomás Cieza | “INVESTIGATION: ANGOR WITH CORONARY ARIES WITHOUT SIGNIFICANT INJURIES.”

 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Check out the best images of the El Salvador 2024 Sessions

Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Arequipa Sessions 2024: Meet the International Guests

The Arequipa Sessions 2024 is getting closer and closer. Meet the international guests who will share their knowledge for 2 days at a high-level...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...